Outcome of Hodgkin's lymphoma and aggressive non-Hodgkin lymphoma patients refractory to salvage chemotherapy

被引：0
|
作者：
Castagna, L. [1 ]
Bramanti, S. [1 ]
Balzarotti, M. [1 ]
Giordano, L. [1 ]
Michieli, M. [2 ]
Anastasia, A. [1 ]
Magagnoli, M. [1 ]
Sarina, B. [1 ]
Todisco, E. [1 ]
Mazza, R. [1 ]
Nozza, A. [1 ]
Ibatici, A. [1 ]
Santoro, A. [1 ]
机构：
[1] Ist Clin Humanitas, Rozzano, Italy
[2] Ctr Riferimento Oncol, I-33081 Aviano, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [11] ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma
    Choi, CW
    Paek, CW
    Seo, JH
    Kim, BS
    Shin, SW
    Kim, YH
    Kim, JS
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (05) : 621 - 624
  • [12] Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma
    Prichard, Mark
    Harris, Thomas
    Williams, Michael E.
    Densmore, John J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (06) : 983 - 995
  • [13] Treatment of aggressive non-Hodgkin's lymphoma
    Coiffier, B
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 12 - 20
  • [14] Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma
    Gillian M. Keating
    [J]. Drugs, 2016, 76 : 1579 - 1586
  • [15] Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Wiernik, Peter H.
    Lossos, Izidore S.
    Tuscano, Joseph M.
    Justice, Glen
    Vose, Julie M.
    Cole, Craig E.
    Lam, Wendy
    McBride, Kyle
    Wride, Kenton
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4952 - 4957
  • [16] Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Weidmann, E
    Kim, SZ
    Rost, A
    Schuppert, H
    Seipelt, G
    Hoelzer, D
    Mitrou, PS
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (08) : 1285 - 1289
  • [17] Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Keating, Gillian M.
    [J]. DRUGS, 2016, 76 (16) : 1579 - 1586
  • [18] Salvage chemotherapy in follicular non-Hodgkin's lymphoma: Focus on tolerability
    Zinzani, Pier Luigi
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (02): : 115 - 124
  • [19] Intensification of salvage treatment with dice dose sequential chemotherapy (HDS) improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin lymphoma (NHL).
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Lussana, F
    Ghielmini, M
    Benedetti, F
    Cantini, M
    Tarella, C
    Zallio, F
    Vitolo, U
    Di Nicola, M
    Pogliani, E
    Cavalli, F
    Barbui, T
    [J]. BLOOD, 2000, 96 (11) : 794A - 794A
  • [20] Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma
    Ziepert, M.
    Schmits, R.
    Trumper, L.
    Pfreundschuh, M.
    Loeffler, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (04) : 752 - 762
12345